Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Gains from Investment Securities (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Gains from Investment Securities for 3 consecutive years, with -$354000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to -$354000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$20000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $5.8 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$354000.0 at Adagio Medical Holdings, down from $231000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $231000.0 in Q3 2025, with the low at -$354000.0 in Q4 2025.
  • Average Gains from Investment Securities over 3 years is $4620.8, with a median of $23000.0 recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 2944.68% in 2025, while the deepest fall reached 147.5% in 2025.
  • Over 3 years, Gains from Investment Securities stood at $45000.0 in 2023, then plummeted by 83.14% to $7587.0 in 2024, then tumbled by 4765.88% to -$354000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$354000.0, $231000.0, and $141000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.